当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析 - 现金流量表

华兰生物

(002007)

  

流通市值:249.27亿  总市值:289.47亿
流通股本:15.74亿   总股本:18.27亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金837,034,153.634,934,564,892.163,552,444,941.922,295,901,505.78
收到的税费返还-10,763,868.93309,649.98309,649.98
收到其他与经营活动有关的现金15,047,349.6968,051,640.9554,326,821.0231,455,218.78
经营活动现金流入的平衡项目0000
经营活动现金流入小计852,081,503.325,013,380,402.043,607,081,412.922,327,666,374.54
购买商品、接受劳务支付的现金416,525,887.581,655,884,984.831,553,707,874.46927,578,583.47
支付给职工以及为职工支付的现金144,793,794.69478,493,657.33337,389,345.7254,218,543.21
支付的各项税费96,652,099.95505,016,300.05342,011,232.97236,351,768.18
支付其他与经营活动有关的现金179,931,139.391,314,640,297.95914,263,533.24588,181,263.98
经营活动现金流出的平衡项目0000
经营活动现金流出小计837,902,921.613,954,035,240.163,147,371,986.372,006,330,158.84
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额14,178,581.711,059,345,161.88459,709,426.55321,336,215.7
二、投资活动产生的现金流量:
收回投资收到的现金4,251,514,785.5123,636,287,582.5317,901,290,166.7511,738,687,058.78
取得投资收益收到的现金71,006,687.85135,294,495.93141,920,968.1116,215,602.11
处置固定资产、无形资产和其他长期资产收回的现金净额25,712892,593.2769,072.52690,239.88
处置子公司及其他营业单位收到的现金净额-1,550,0001,550,0007,030.28
投资活动现金流入的平衡项目0000
投资活动现金流入小计4,322,547,185.3623,774,024,671.6618,045,530,207.3711,855,599,931.05
购建固定资产、无形资产和其他长期资产支付的现金67,866,067.66255,428,449.3457,425,868.78260,388,845.16
投资支付的现金4,611,335,357.2623,428,157,926.6117,569,564,573.6110,424,087,847.62
支付其他与投资活动有关的现金12,840362,323.91-362,323.91
投资活动现金流出的平衡项目0000
投资活动现金流出小计4,679,214,264.9223,683,948,699.8218,026,990,442.3910,684,839,016.69
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-356,667,079.5690,075,971.8418,539,764.981,170,760,914.36
三、筹资活动产生的现金流量:
吸收投资收到的现金-16,281,00016,281,00016,281,000
取得借款收到的现金278,704,844.44596,468,571.01300,000,000300,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计278,704,844.44612,749,571.01316,281,000316,281,000
偿还债务支付的现金100,000,000700,000,000250,000,000.01150,000,000.01
分配股利、利润或偿付利息支付的现金97,612,869.43585,446,171.58586,908,790.4582,717,423.22
其中:子公司支付给少数股东的股利、利润-117,616,500117,009,000117,009,000
支付其他与筹资活动有关的现金-107,736,520.27107,167,606.3939,127,951.38
筹资活动现金流出平衡项目0000
筹资活动现金流出小计197,612,869.431,393,182,691.85944,076,396.8771,845,374.61
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额81,091,975.01-780,433,120.84-627,795,396.8-455,564,374.61
四、汇率变动对现金及现金等价物的影响75,438.63-52,406.71-45,954.89-97,151
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-261,321,084.21368,935,606.17-149,592,160.161,036,435,604.45
加:期初现金及现金等价物余额1,358,260,221.68989,324,615.51989,324,615.51989,324,615.51
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,096,939,137.471,358,260,221.68839,732,455.352,025,760,219.96
补充资料:
净利润-1,155,469,792.25-448,775,270.53
资产减值准备-74,225,065.72--
固定资产和投资性房地产折旧-248,723,026.77-122,405,583.04
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-248,723,026.77-122,405,583.04
无形资产摊销-11,732,164.68-5,731,565.79
长期待摊费用摊销-11,314,041.8-5,469,673.24
处置固定资产、无形资产和其他长期资产的损失--78,661.39--122,811.82
固定资产报废损失-5,709,620.93-2,034,397.69
公允价值变动损失--32,940,014.29--19,356,426.44
财务费用-13,124,519.99-8,372,221.48
投资损失--137,517,910.98--67,879,421.27
递延所得税-3,707,251.35--2,746,010.84
其中:递延所得税资产减少-6,385,601.46--741,284.77
递延所得税负债增加--2,678,350.11--2,004,726.07
存货的减少--416,884,677.76--248,989,496.05
经营性应收项目的减少-840,461,407.42-412,483,525.59
经营性应付项目的增加--723,825,743.11--328,732,690.81
其他-11,084,642.93-23,981,670.54
现金的期末余额-1,358,260,221.68-2,025,760,219.96
减:现金的期初余额-989,324,615.51-989,324,615.51
公告日期2025-04-282025-03-292024-10-302024-08-30
审计意见(境内)标准无保留意见
TOP↑